See also this year's filing and all EDGAR filings for this company.
PDF Report 0001621443_2021_Zynerba_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'OperatingIncomeLoss'} |
Graph
Absolute values for 0001621443, Zynerba Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 73,366,174 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 585,403 |
| 3 | remainder_Assets | 105,199 |
| 4 | LiabilitiesCurrent | 13,913,248 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 18,527,150 |
| 9 | ResearchAndDevelopmentExpense | 36,809,569 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 74,056,776 |
| 1 | Liabilities | 13,913,248 |
| 2 | Expenses | 55,336,719 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 60,143,528 |
| 5 | NetIncome | -55,336,719 |
| 6 | ComprehensiveNetIncome | -55,336,719 |
| 7 | BaseVar | 71,653,372 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.72 |
| 9 | EconomicCapitalRatio | 2.84 |
Edgar->Model Mapping
Feature Distribution
Change over Time
